サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1579749

胆道ステントの世界市場

Biliary Stents

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
胆道ステントの世界市場
出版日: 2024年10月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

胆道ステントの世界市場は2030年までに7億9,780万米ドルに達する見込み

2023年に6億1,360万米ドルと推定された胆道ステントの世界市場は、2030年には7億9,780万米ドルに達し、分析期間2023-2030年のCAGRは3.8%で成長すると予測されます。本レポートで分析したセグメントの1つである外来手術センター（Ambulatory Surgery Centers End-Use）は、CAGR 3.5％を記録し、分析期間終了までに3億6,900万米ドルに達すると予測されます。病院エンドユースセグメントの成長率は、分析期間中CAGR 4.2%と推定されます。

米国市場は1億6,600万米ドルと推定、中国はCAGR6.3%で成長予測

米国の胆道ステント市場は、2023年に1億6,600万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億6,240万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1%と3.1%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界の胆道ステント市場- 主要動向と促進要因まとめ

胆道ステントとは何か？

胆道ステントは、胆管の開通性を維持し、肝臓から腸への胆汁の適切な流れを確保するために、胆管に挿入される小型の管状デバイスです。これらのステントは主に、胆管がん、膵がん、胆石、瘢痕化や炎症による良性の狭窄などの疾患による胆管閉塞の治療に使用されます。胆管の閉塞は、黄疸、胆汁性肝硬変、胆管炎などの生命を脅かす感染症などの重篤な合併症を引き起こす可能性があります。胆道ステントは、胆汁の排出経路を確保することでこれらの閉塞を緩和し、症状を軽減し、合併症を予防します。ステントはプラスチック製と金属製の2種類に大別されます。プラスチック製ステントは時間の経過とともに閉塞する傾向があるため、一般的に短期的な管理に使用されるが、自己拡張型金属ステント（SEMS）は内腔が大きく、閉塞しにくいため、長期的な解決策に好まれます。胆道ステントは、閉塞の性質に応じて内視鏡的または経皮的に留置することができ、患者の転帰とQOLを改善するための緩和ケアと術前介入の両方において不可欠なツールと考えられています。症状を軽減し、胆汁の流れを改善する胆道ステントは、悪性および良性の胆道疾患管理の要となっています。

技術の進歩が胆道ステントをより効果的にしているのですか？

最近の技術進歩は、胆道ステントの有効性、耐久性、安全性を著しく向上させ、その応用範囲を広げ、患者の転帰を改善しています。最も注目すべき進歩のひとつは、従来の金属ステントで一般的な問題であった組織の浸潤や移動を防ぐように設計された被覆自己拡張型金属ステント（CSEMS）の出現です。これらのステントはポリテトラフルオロエチレン（PTFE）やシリコーンなどの生体適合性材料でコーティングされており、腫瘍の過成長を最小限に抑え、ステントの開存期間を延長する効果的なバリアを提供しています。フレアエンドやアンカー機構などのステント移動防止機能の使用により、インターベンションを繰り返す必要のある合併症であるステント移動のリスクはさらに減少しました。さらに、時間の経過とともに徐々に溶解する生分解性ステントの導入は、良性の狭窄に対する有望な解決策を提供し、ステント除去処置の必要性を排除しています。このステントは化学療法剤や抗増殖剤でコーティングされており、局所的に薬剤を放出することで腫瘍の成長や瘢痕組織の形成を抑制し、ステントの機能寿命を延長します。ステントデリバリーシステムの改良も重要な役割を果たしており、新しいデバイスは曲がりくねった解剖学的構造でもより正確な配置を可能にしています。これらのデリバリー・システムは現在、押しやすさ、柔軟性、画像ガイダンス下での視認性が向上しており、消化器内科医やインターベンショナル・ラジオロジストが複雑な胆管構造をより容易にナビゲートできるようになっています。このような技術的進歩は、胆道ステントの有効性と安全性プロファイルを向上させるだけでなく、悪性・良性両方の胆道疾患管理における役割を拡大しつつあります。

治療パラダイムの変化と患者層は胆道ステント市場をどのように形成しているか？

胆道ステント市場は、治療パラダイムの進化、世界人口の高齢化、胆道疾患と膵疾患の発生率の増加によって形成されています。高齢化、肥満、アルコール関連肝疾患などの要因によって肝胆道系がんの有病率が上昇を続ける中、効果的な胆道減圧ソリューションに対する需要が急速に高まっています。このことは治療戦略の転換をもたらし、胆道ステントは緩和ケアと根治的介入の両方においてますます中心的な役割を果たすようになってきています。例えば、手術不能の胆管がんや膵臓がんの患者において、胆道ステント留置術は、黄疸やその他の症状を効果的に緩和し、患者のQOLを改善し、化学療法を容易にすることから、現在では管理プロトコールの標準的な一部となっています。さらに、低侵襲の内視鏡的逆行性胆管膵管造影（ERCP）手技の使用が拡大しているため、より高い精度で展開でき、合併症の少ないステントに対する需要が高まっています。世界の人口の高齢化は胆管閉塞と関連合併症の有病率の上昇につながるため、患者の人口動態も市場動向に影響を与えています。このような人口統計学的傾向は、再手術の理想的な候補者ではない可能性のある高齢患者における再手術の頻度を減らすことができる、より耐久性が高く長持ちするステントオプションの必要性に拍車をかけています。さらに、快適性と留置のしやすさを優先した患者中心の設計や、小児・思春期患者向けの特殊なステントの開発が重視されるようになっています。オーダーメイドのソリューションを求めるこの動向は、技術革新をさらに促進し、メーカーが臨床性能と患者の転帰に基づいて製品を差別化する機会を生み出しています。

胆道ステント市場の急成長を促進する要因は？

胆道ステント市場の成長は、胆道疾患の有病率の増加、ステント設計の技術進歩、低侵襲手技の採用増加など、いくつかの要因によってもたらされます。特に肝胆膵がんの増加を背景とした胆道閉塞の罹患率の増加は主要な促進要因の一つであり、胆道ステントは罹患患者の症状を管理しQOLを向上させるための重要な緩和的介入です。自己拡張型金属ステント（SEMS）、被覆型ステント、生分解性ステントなどの技術革新も、ステントの閉塞や移動といった一般的な合併症に対処することでステントの寿命を延ばし、再手術の必要性を減らすことで市場の成長に大きく寄与しています。さらに、ERCPや経皮的ステント留置術のような低侵襲手技への動向は、これらの手技が従来の外科的アプローチと比較して回復時間の短縮や合併症発生率の低下と関連していることから、胆道ステントの使用を拡大しています。胆道疾患に対する認識の高まりと早期発見は、内視鏡的介入への嗜好の高まりと相まって、高度なステント留置オプションの需要をさらに高めています。さらに、胆管がん、胆石症、その他の胆道病変に罹患しやすい世界人口の高齢化が、効果的で耐久性のあるステント留置ソリューションの必要性を高めています。最後に、ヘルスケア業界では価値に基づく医療が重視されているため、臨床効果とコスト効率の両方を提供するステントへのシフトが促されており、医療システム全体の負担を軽減しながら患者の転帰を改善する革新的なステント技術の採用が増加しています。こうした多様な要因によって胆道ステント市場は変貌を遂げ、効果的な胆道ドレナージソリューションに対する需要が高まり続ける中で、持続的な成長が期待できるようになっています。

調査対象企業の例（全42件）

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17706

Global Biliary Stents Market to Reach US$797.8 Million by 2030

The global market for Biliary Stents estimated at US$613.6 Million in the year 2023, is expected to reach US$797.8 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Ambulatory Surgery Centers End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$369.0 Million by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.0 Million While China is Forecast to Grow at 6.3% CAGR

The Biliary Stents market in the U.S. is estimated at US$166.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$162.4 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Biliary Stents Market - Key Trends and Drivers Summarized

What Are Biliary Stents and Why Are They Used?

Biliary stents are small, tubular devices inserted into the bile duct to maintain its patency and ensure the proper flow of bile from the liver to the intestine. These stents are primarily used in the treatment of bile duct obstructions caused by conditions such as cholangiocarcinoma (bile duct cancer), pancreatic cancer, gallstones, or benign strictures due to scarring and inflammation. Obstruction in the bile duct can lead to serious complications, including jaundice, biliary cirrhosis, and life-threatening infections such as cholangitis. Biliary stents help alleviate these blockages by providing a pathway for bile drainage, reducing symptoms, and preventing complications. The stents are categorized into two major types: plastic and metal. Plastic stents are generally used for short-term management due to their tendency to occlude over time, while self-expanding metallic stents (SEMS) are preferred for longer-term solutions because they provide a larger lumen and resist clogging. Biliary stents can be placed endoscopically or percutaneously depending on the nature of the obstruction, and are considered an essential tool in both palliative care and preoperative interventions to improve patient outcomes and quality of life. With their ability to reduce symptoms and improve bile flow, biliary stents have become a cornerstone in the management of malignant and benign biliary diseases.

How Are Technological Advances Making Biliary Stents More Effective?

Recent technological advancements have significantly enhanced the efficacy, durability, and safety of biliary stents, broadening their applications and improving patient outcomes. One of the most noteworthy developments is the advent of covered self-expanding metallic stents (CSEMS), which are designed to prevent tissue ingrowth and migration, common issues with traditional metal stents. These stents are coated with biocompatible materials such as polytetrafluoroethylene (PTFE) or silicone, providing an effective barrier that minimizes tumor overgrowth and prolongs stent patency. The use of anti-migration features, such as flared ends and anchoring mechanisms, has further reduced the risk of stent displacement, a complication that can necessitate repeat interventions. Additionally, the introduction of biodegradable stents, which gradually dissolve over time, offers a promising solution for benign strictures, eliminating the need for stent removal procedures. Another major innovation is the use of drug-eluting stents, which are coated with chemotherapeutic agents or anti-proliferative drugs that release medication locally to inhibit tumor growth or scar tissue formation, thereby extending the functional life of the stent. Improvements in stent delivery systems have also played a crucial role, with newer devices allowing for more precise deployment even in tortuous anatomy. These delivery systems are now equipped with enhanced pushability, flexibility, and visibility under imaging guidance, enabling gastroenterologists and interventional radiologists to navigate complex bile duct anatomy with greater ease. Such technological advancements are not only improving the effectiveness and safety profile of biliary stents but are also expanding their role in the management of both malignant and benign biliary conditions.

How Are Shifting Treatment Paradigms and Patient Demographics Shaping the Biliary Stent Market?

The biliary stent market is being shaped by evolving treatment paradigms, an aging global population, and the increasing incidence of biliary and pancreatic diseases. As the prevalence of hepatobiliary cancers continues to rise, driven by factors such as aging populations, obesity, and alcohol-related liver diseases, the demand for effective biliary decompression solutions is growing rapidly. This has led to a shift in treatment strategies, with biliary stents playing an increasingly central role in both palliative care and curative interventions. For instance, in patients with inoperable cholangiocarcinoma or pancreatic cancer, biliary stenting is now a standard part of the management protocol, as it effectively alleviates jaundice and other symptoms, improving the patient’s quality of life and facilitating chemotherapy. Furthermore, the expanding use of minimally invasive endoscopic retrograde cholangiopancreatography (ERCP) procedures has driven demand for stents that can be deployed with greater precision and fewer complications. Patient demographics are also influencing market trends, as an aging global population leads to a higher prevalence of bile duct obstructions and related complications. This demographic trend has spurred the need for more durable, long-lasting stent options that can reduce the frequency of reinterventions in elderly patients who may not be ideal candidates for repeated procedures. Moreover, there is a growing emphasis on patient-centric designs that prioritize comfort and ease of placement, as well as the development of specialized stents for pediatric and adolescent patients. This trend toward tailored solutions is further driving innovation and creating opportunities for manufacturers to differentiate their products based on clinical performance and patient outcomes.

What Factors Are Driving the Rapid Growth of the Biliary Stent Market?

The growth in the biliary stent market is driven by several factors, including the increasing prevalence of biliary diseases, technological advancements in stent design, and the rising adoption of minimally invasive procedures. The growing incidence of biliary obstructions, particularly in the context of rising hepatobiliary and pancreatic cancers, is one of the primary drivers, as biliary stents are a key palliative intervention for managing symptoms and improving the quality of life in affected patients. Technological innovations, such as the development of self-expanding metal stents (SEMS), covered stents, and biodegradable stents, are also contributing significantly to market growth by addressing common complications like stent occlusion and migration, thereby extending stent longevity and reducing the need for repeat procedures. Additionally, the trend toward minimally invasive techniques, such as ERCP and percutaneous stenting, is expanding the use of biliary stents as these procedures are associated with shorter recovery times and lower complication rates compared to traditional surgical approaches. Increased awareness and early detection of biliary diseases, coupled with a growing preference for endoscopic interventions, are further bolstering the demand for advanced stenting options. Moreover, the aging global population, which is more susceptible to conditions like cholangiocarcinoma, gallstone disease, and other biliary pathologies, is driving the need for effective and durable stenting solutions. Finally, the healthcare industry’s emphasis on value-based care is prompting a shift toward stents that offer both clinical efficacy and cost-efficiency, leading to increased adoption of innovative stent technologies that improve patient outcomes while reducing the overall burden on healthcare systems. These diverse factors are transforming the biliary stent market, positioning it for sustained growth as the demand for effective biliary drainage solutions continues to rise.

Select Competitors (Total 42 Featured) -

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biliary Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Biliary Diseases Throws the Spotlight on Stenting Solutions
    • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Biliary Stents
    • Technological Innovations in Stent Design Propel Growth with Enhanced Patency Rates
    • Here's the Story: Expanding Geriatric Population Base Sustains Growth in Biliary Stent Adoption
    • Emergence of Metal & Bioabsorbable Stents Expands Addressable Market for Advanced Solutions
    • Here's How Rising Incidence of Pancreatic & Liver Cancers Spurs Demand in Oncology Applications
    • Rising Awareness of Non-Surgical Treatment Options Drives Adoption in High-Risk Patient Groups
    • Shift Toward Personalized Medicine Generates Opportunities for Customized Stent Solutions
    • Growing Preference for Endoscopic Ultrasound-Guided Procedures Expands Stent Utilization
    • Innovations in Coating Materials & Drug-Eluting Technologies Create Niche Growth Potential
    • Improved Imaging Techniques for Diagnosis & Placement Accelerate Adoption in Complex Cases
    • Rising Focus on Reducing Post-Procedural Complications Spurs Innovations in Stent Engineering
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Biliary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION